chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: Fatigued/felt tired; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigued/felt tired) and VACCINATION SITE PAIN (Sore arm) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045C21A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, the patient experienced FATIGUE (Fatigued/felt tired) and VACCINATION SITE PAIN (Sore arm). At the time of the report, FATIGUE (Fatigued/felt tired) and VACCINATION SITE PAIN (Sore arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported.   This case was linked to MOD-2021-365820, MOD-2021-365922 (Patient Link).
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired vaccine given to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine given to patient) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine given to patient). On 27-Oct-2021, EXPIRED PRODUCT ADMINISTERED (expired vaccine given to patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was administered with vaccine which was punctured the day before 26-oct-2021 at 3 pm. No adverse reactions were reported as far. Concomitant medications were not provided. Treatment information was not provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Inappropriate schedule of product administration
Clinical narrative: first dose greater than 25 days\my second shot was 16Sep2021, five months later/2nd dose >36 days; tired/fatigued; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired/fatigued) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose greater than 25 days\my second shot was 16Sep2021, five months later/2nd dose >36 days) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced FATIGUE (tired/fatigued). On 16-Sep-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose greater than 25 days\my second shot was 16Sep2021, five months later/2nd dose >36 days). On 16-Sep-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose greater than 25 days\my second shot was 16Sep2021, five months later/2nd dose >36 days) had resolved. At the time of the report, FATIGUE (tired/fatigued) outcome was unknown.            No concomitant medications were provided.  No treatment medications were provided It was reported that the patient felt fine after the second dose, except tired/fatigued.   Most recent FOLLOW-UP information incorporated above includes: On 28-Oct-2021: Follow up received: New event (fatigue) was added. Vaccine administration site updated.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: vaccine was administered to 1 patient past the 30-day refrigeration date; Product storage error; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine was administered to 1 patient past the 30-day refrigeration date) and PRODUCT STORAGE ERROR (Product storage error) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine was administered to 1 patient past the 30-day refrigeration date) and PRODUCT STORAGE ERROR (Product storage error). On 27-Oct-2021, EXPIRED PRODUCT ADMINISTERED (vaccine was administered to 1 patient past the 30-day refrigeration date) and PRODUCT STORAGE ERROR (Product storage error) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included Menopause (Menopause at 40 years).  On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (Sore arm). The patient was treated with IBUPROFEN for Pain, at a dose of 1 dosage form and CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) for Adverse event, at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   Other treatment: cold packs No concomitant information were reported by the reporter   This case was linked to MOD-2021-365743 (Patient Link).
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered expired doses to patients past the published expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired doses to patients past the published expiration date) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired doses to patients past the published expiration date). On 20-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Administered expired doses to patients past the published expiration date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that the vial was initially stored in the refrigerator on 20-Oct-2021.   Concomitant medications were not provided. Treatment medication was not provided.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: gave a minor their 1st dose of the Moderna Covid-19 Vaccine; Inappropriate age at vaccine administration; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (gave a minor their 1st dose of the Moderna Covid-19 Vaccine) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) in a 13-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Oct-2021, the patient experienced WRONG PRODUCT ADMINISTERED (gave a minor their 1st dose of the Moderna Covid-19 Vaccine) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration). On 21-Oct-2021, WRONG PRODUCT ADMINISTERED (gave a minor their 1st dose of the Moderna Covid-19 Vaccine) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported.  No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: had COVID-19 a month ago; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (had COVID-19 a month ago) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In September 2021, the patient experienced COVID-19 (had COVID-19 a month ago). At the time of the report, COVID-19 (had COVID-19 a month ago) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications are provided.  No treatment medications are provided.  Patient reported that the patient had COVID-19 a month ago after receiving the first two Moderna COVID-19 vaccinations 6 months ago. The patient wanted the booster dose now. The nurse wanted to know about the rules they had to follow regarding administration after SARS-COV-2 infection. The case concerns a  female patient of unknown age with no previous relevant medical history, who experienced the unexpected adverse event on especial interest of COVID-19. The event occurred approximately 6 months after the second dose of Spikevax, however, vaccination dates and onset date of event were not disclosure. The rechallenge was unknown since there's no information about the first dose. The benefit-risk relationship of Spikevax is not affected by this report.; Sender's Comments: The case concerns a  female patient of unknown age with no previous relevant medical history, who experienced the unexpected adverse event on especial interest of COVID-19. The event occurred approximately 6 months after the second dose of Spikevax, however, vaccination dates and onset date of event were not disclosure. The rechallenge was unknown since there's no information about the first dose. The benefit-risk relationship of Spikevax is not affected by this report.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Illness, Peripheral swelling, Pyrexia
Clinical narrative: Swollen arm, about the size of a tennis ball; Fever of 102 degrees Fahrenheit; Pretty sick/Sick for about a half of a day after receiving the dose; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Pretty sick/Sick for about a half of a day after receiving the dose), PERIPHERAL SWELLING (Swollen arm, about the size of a tennis ball) and PYREXIA (Fever of 102 degrees Fahrenheit) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Pretty sick/Sick for about a half of a day after receiving the dose), PERIPHERAL SWELLING (Swollen arm, about the size of a tennis ball) and PYREXIA (Fever of 102 degrees Fahrenheit). At the time of the report, ILLNESS (Pretty sick/Sick for about a half of a day after receiving the dose) and PYREXIA (Fever of 102 degrees Fahrenheit) had resolved and PERIPHERAL SWELLING (Swollen arm, about the size of a tennis ball) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 degrees fahrenheit (High) 102 degrees Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products were reported. No treatment information was reported by the reporter. The patient stated that  during the call he  was over 65 years old. The patient stated that he must have had a robust immune response to the prior two doses and stated that his doctor had suggested pre-medicate with Tylenol before receiving the booster shot.   This case was linked to MOD-2021-366108, MOD-2021-366140 (Patient Link).
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was administered a dose from an expired vial.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose from an expired vial.) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose from an expired vial.). On 12-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose from an expired vial.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment reported   This case was linked to MOD-2021-366918 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered vaccine past the published expiration date; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED. On 27-Oct-2021, EXPIRED PRODUCT ADMINISTERED had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that the vial was initially stored in the refrigerator on 30September2021.  No treatment medications were reported.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Felt like he had the flu; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like he had the flu) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Felt like he had the flu). At the time of the report, INFLUENZA LIKE ILLNESS (Felt like he had the flu) outcome was unknown.            No Concomitant medications were provided. No treatment medications were provided.   This case was linked to MOD-2021-366041, MOD-2021-366140 (Patient Link).   Reporter did not allow further contact
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dose administered to patient after 30 day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient after 30 day Use By Date) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient after 30 day Use By Date). On 14-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient after 30 day Use By Date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant information was not provided.  It was reported that the officer received Moderna vaccine on 2-Sep-2021 but was unaware that the vial should have been discarded on 02-Oct-2021.They are not sure that the vail was thawed on 2-Sep-2021.The vial didn't undergo any temperature excursions.  Treatment information was not provided.   This case was linked to MOD-2021-366199 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen arm). At the time of the report, PERIPHERAL SWELLING (Swollen arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment reported.   This case was linked to MOD-2021-366041, MOD-2021-366108, MOD-2021-366045 (Patient Link).
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination complication
Clinical narrative: Feeling horrible after 2nd shot; Fever 101F after 2nd shot; This spontaneous case was reported by a nurse and describes the occurrence of FEELING ABNORMAL (Feeling horrible after 2nd shot) and PYREXIA (Fever 101F after 2nd shot) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Type I diabetes mellitus. Concomitant products included INSULIN LISPRO PROTAMINE SUSPENSION (HUMALOG N) for Type I diabetes mellitus.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced FEELING ABNORMAL (Feeling horrible after 2nd shot) and PYREXIA (Fever 101F after 2nd shot). At the time of the report, FEELING ABNORMAL (Feeling horrible after 2nd shot) and PYREXIA (Fever 101F after 2nd shot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Apr-2021, Blood glucose: 400 mg/dl (High) could not get the BG to go under 400 mg/dL for 18 hours. On 09-Apr-2021, Body temperature: 101 (High) had a Fever 101F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Treatment medications were reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: the first time she had that sensation when it was going in. It felt strange; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced FEELING ABNORMAL. At the time of the report, FEELING ABNORMAL outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant product use was not provided by the reporter. No treatment information was provided.   This case was linked to MOD-2021-366094 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Headache, Hyperhidrosis, Nausea
Clinical narrative: Body is achy; Started sweating it out; Still sick to my stomach; Nauseous; A pounding head ache; Temperature was like a 101°F/between 99°F and 100°F during the day/100.2°F/moderate fever/low grade fever 99.5°F; I had the chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN, HYPERHIDROSIS, ABDOMINAL DISCOMFORT, NAUSEA, and HEADACHE in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039D21A, 038K20A, and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In October 2021, the patient experienced PAIN, HYPERHIDROSIS, ABDOMINAL DISCOMFORT, NAUSEA, HEADACHE, PYREXIA, and CHILLS. The patient was treated with TYLENOL at an unspecified dose and frequency. At the time of the report, PAIN and NAUSEA had not resolved and HYPERHIDROSIS, ABDOMINAL DISCOMFORT, HEADACHE, PYREXIA, and CHILLS outcome was unknown.            No Concomitant medication was reported.   This case was linked to MOD-2021-366173 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Body is achy; Started sweating it out; Still sick to my stomach; Nauseous; A pounding head ache; Temperature was like a 101°F/between 99°F and 100°F during the day/100.2°F/moderate fever/low grade fever 99.5°F; I had the chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN, HYPERHIDROSIS, ABDOMINAL DISCOMFORT, NAUSEA, and HEADACHE in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039D21A, 038K20A, and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In October 2021, the patient experienced PAIN, HYPERHIDROSIS, ABDOMINAL DISCOMFORT, NAUSEA, HEADACHE, PYREXIA, and CHILLS. The patient was treated with TYLENOL at an unspecified dose and frequency. At the time of the report, PAIN and NAUSEA had not resolved and HYPERHIDROSIS, ABDOMINAL DISCOMFORT, HEADACHE, PYREXIA, and CHILLS outcome was unknown.            No Concomitant medication was reported.   This case was linked to MOD-2021-366173 (Patient Link).
Age: 54.0
Sex: U
Vaccine: COVID19
Symptoms: Chest pain, Dizziness
Clinical narrative: Feels like hit in the chest with a softball,pain in the chest; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Feels like hit in the chest with a softball,pain in the chest) and DIZZINESS (Dizziness) in a 54-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 04C21A, 018821A and 046821A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced CHEST PAIN (Feels like hit in the chest with a softball,pain in the chest) and DIZZINESS (Dizziness). At the time of the report, CHEST PAIN (Feels like hit in the chest with a softball,pain in the chest) and DIZZINESS (Dizziness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was provided. patient stated that he had Cardiac related signs and symptoms: Chest pressure rapid heart rate.
Age: 79.0
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: This spontaneous case reported by a nurse, describes the occurrence of inappropriate schedule of product administration (did not get their second dose in time/dose administered greater than 42 days) in a 79-year-old patient, of an unknown gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Apr 5, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced inappropriate schedule of product administration (did not get their second dose in time/dose administered greater than 42 days). At the time of the report, inappropriate schedule of product administration (did not get their second dose in time/dose administered greater than 42 days) resolved. The reporter did not provide any causality assessments, concomitant medication or treatment information.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: arm pain (injection site); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm pain (injection site)) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939904) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced VACCINATION SITE PAIN (arm pain (injection site)). At the time of the report, VACCINATION SITE PAIN (arm pain (injection site)) outcome was unknown.            Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Headache, Heart rate, Myalgia, Pyrexia
Clinical narrative: Arm  pain; Muscle pain; Headache; Fever; Chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm  pain), MYALGIA (Muscle pain), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concurrent medical conditions included Dry cough.    On 24-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced VACCINATION SITE PAIN (Arm  pain), MYALGIA (Muscle pain), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, VACCINATION SITE PAIN (Arm  pain), MYALGIA (Muscle pain), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Oct-2021, Heart rate: rapid (High) Rapid.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment drugs were reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm  pain; Muscle pain; Headache; Fever; Chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm  pain), MYALGIA (Muscle pain), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concurrent medical conditions included Dry cough.    On 24-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced VACCINATION SITE PAIN (Arm  pain), MYALGIA (Muscle pain), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, VACCINATION SITE PAIN (Arm  pain), MYALGIA (Muscle pain), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Oct-2021, Heart rate: rapid (High) Rapid.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment drugs were reported.
Sex: U
Vaccine: COVID19
Symptoms: Poor quality product administered, Product temperature excursion issue
Clinical narrative: an unknown amount of patients was administered a dose which undergone a temperature excursion; poor quality vaccine administered; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (an unknown amount of patients was administered a dose which undergone a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (poor quality vaccine administered) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Sep-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (an unknown amount of patients was administered a dose which undergone a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (poor quality vaccine administered). On 26-Sep-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (an unknown amount of patients was administered a dose which undergone a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (poor quality vaccine administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The HCP reported that an unknown amount of patients were administered a dose which undergone a temperature excursion 10 vials were administered to the patients, mostly they had a lot of waste. 1 or 2 patients might have received the vaccine. No concomitant medications were reported. No treatment medications were reported.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia
Clinical narrative: Severe Joint pain; Muscle pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Severe Joint pain), MYALGIA (Muscle pain) and HEADACHE (Headache) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017F21A, 030L20A and 039K20A) for COVID-19 vaccination.     Concurrent medical conditions included Clotting disorder (Clotting concerns) and Cholesterol. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for Hypercholesterolaemia, ASPIRIN [ACETYLSALICYLIC ACID] for Thrombosis, SPIRONOLACTONE (ALDACTONE [SPIRONOLACTONE]), ETHINYLESTRADIOL, NORGESTIMATE (TRINESSA), AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), ESCITALOPRAM OXALATE (LEXAPRO) and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Severe Joint pain), MYALGIA (Muscle pain) and HEADACHE (Headache). At the time of the report, ARTHRALGIA (Severe Joint pain), MYALGIA (Muscle pain) and HEADACHE (Headache) outcome was unknown.            Treatment information was not provided. It was reported that  Patient when she got the vaccine it was extremely painful and sharp the shot, and she had bleeding on the injection site for +15 hrs there was lots of fresh bleeding. It's starting to bruise underneath.   This case was linked to MOD-2021-366416, MOD-2021-366435 (Patient Link).
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia
Clinical narrative: severe joint pain; severe muscle pain; headache; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (severe joint pain), MYALGIA (severe muscle pain) and HEADACHE (headache) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A, 030L20A and 017F21A) for COVID-19 vaccination.     The patient's past medical history included Clotting disorder (Clotting concerns). Concurrent medical conditions included Cholesterol. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for Cholesterol, SPIRONOLACTONE (ALDACTONE [SPIRONOLACTONE]), ETHINYLESTRADIOL, NORGESTIMATE (TRINESSA), AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), ESCITALOPRAM OXALATE (LEXAPRO), ASPIRIN [ACETYLSALICYLIC ACID] and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (severe joint pain), MYALGIA (severe muscle pain) and HEADACHE (headache). At the time of the report, ARTHRALGIA (severe joint pain), MYALGIA (severe muscle pain) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided by the reporter. It was reported that patient sometimes takes daily aspirin because had a history with cloting concerns   This case was linked to MOD-2021-366416, MOD-2021-366431 (Patient Link).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Aphthous ulcer, Gingival swelling
Clinical narrative: My gums  have white spots, got worse after booster dose; My gums  have white spots, got worse after booster dose; This spontaneous case was reported by a consumer and describes the occurrence of GINGIVAL SWELLING (My gums  have white spots, got worse after booster dose) and APHTHOUS ULCER (My gums  have white spots, got worse after booster dose) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020F21A, 002A21A and 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cancer (Had history of cancer and was seen by oncologist who ruled out leukemia.). Concomitant products included LOSARTAN, LEVOTHYROXINE and ANASTROZOLE (ANASTRAZOLE DENK) for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced GINGIVAL SWELLING (My gums  have white spots, got worse after booster dose) and APHTHOUS ULCER (My gums  have white spots, got worse after booster dose). At the time of the report, GINGIVAL SWELLING (My gums  have white spots, got worse after booster dose) and APHTHOUS ULCER (My gums  have white spots, got worse after booster dose) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had experienced inflammation in the gums, white spots, deep red inflammation/swelling. The side effect started after the second dose and got worse after the third dose.Patient had seen 3-4 doctors and a biopsy on gums to rule out lupus, oral surgeon could not diagnose. The symptoms are still ongoing, patient will see a rheumatologist on 26OCT2021.  Treatment medications include Antibiotics of unspecified name   This case was linked to MOD-2021-365942 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Tenderness
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of tenderness (tenderness on arm), erythema (redness) and feeling hot in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. October 2021, patient received the third (booster) dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced  tenderness (tenderness on arm), erythema (redness) and feeling hot. At the time of the report,  tenderness (tenderness on arm), erythema (redness) and feeling hot outcome: unknown. No concomitant medications or treatment information provided. The patient wanted to figure out whether to put ice on it. Reporter did not allow further contact.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was administered a dose from an expired vial.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose from an expired vial.) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose from an expired vial.). On 13-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose from an expired vial.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment medications were reported.   This case was linked to MOD-2021-366918, MOD-2021-366925 (Patient Link).
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: patient received booster dose 5 months after second dose instead of 6 months; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received booster dose 5 months after second dose instead of 6 months) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A, 038B21A and 076C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received booster dose 5 months after second dose instead of 6 months). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received booster dose 5 months after second dose instead of 6 months) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment informations were reported.    This case was linked to MOD-2021-366704 (Patient Link).
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy, Erythema, Feeling hot, Swelling face
Clinical narrative: red/never ever had fillers or Botox, or anything like that; warm; Cheek swelling; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red/never ever had fillers or Botox, or anything like that), FEELING HOT (warm) and SWELLING FACE (Cheek swelling) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038C21A, 025A21A and 029L20A) for COVID-19 vaccination.     The patient's past medical history included Heart attack. Concurrent medical conditions included Blood pressure, Breast cancer, Cholesterol and Asthma.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, the patient experienced ERYTHEMA (red/never ever had fillers or Botox, or anything like that), FEELING HOT (warm) and SWELLING FACE (Cheek swelling). At the time of the report, ERYTHEMA (red/never ever had fillers or Botox, or anything like that), FEELING HOT (warm) and SWELLING FACE (Cheek swelling) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Biopsy: cancer (abnormal) Cancer.         Concomitant products included 9 prescription medications, Blood thinners, Blood pressure pills, Cholesterol thing, and Inhaler in the morning for asthma. Patient has a surgery scheduled for November 6th. No treatment medication details was reported.   This case was linked to MOD-2021-366737 (Patient Link).
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was administered a dose from an expired vial; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose from an expired vial) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose from an expired vial). On 15-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose from an expired vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided. No treatment information was provided. Expiration date was  11 Oct 2021.   This case was linked to MOD-2021-366918, MOD-2021-365543, MOD-2021-365600, MOD-2021-365692, MOD-2021-365742, MOD-2021-365891, MOD-2021-366043, MOD-2021-366226, MOD-2021-366595 (Patient Link).
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 13 doses administered 25Oct2021/this lot number has an expiration date of 10/24/2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (13 doses administered 25Oct2021/this lot number has an expiration date of 10/24/2021) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 ml. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (13 doses administered 25Oct2021/this lot number has an expiration date of 10/24/2021). On 25-Oct-2021, EXPIRED PRODUCT ADMINISTERED (13 doses administered 25Oct2021/this lot number has an expiration date of 10/24/2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Oct-2021: Follow up received contains no new information.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: Achy; Tired,felt fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy) and FATIGUE (Tired,felt fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN (Achy) and FATIGUE (Tired,felt fatigue). At the time of the report, PAIN (Achy) and FATIGUE (Tired,felt fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient stated the intensity of the events were more severe than the first Moderna Covid-19 vaccine.  Concomitant product use was not provided by the reporter. Treatment information was not provided by the reporter.   This case was linked to MOD-2021-366366, MOD-2021-367209 (Patient Link).